Automated XPS Analysis of Passivated Stainless Steel to the SEMI Standard

Autor: RG White, Richard J. Lee, BR Strohmeier, JD Piasecki, Tim Nunney

Publikováno v: Microscopy and Microanalysis. 16:436-437

Extended abstract of a paper presented at Microscopy and Microanalysis 2010 in Portland, Oregon, USA, August 1 – August 5, 2010.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::db8a0cc7e3d0a8f35facb95e0cc761ad
https://doi.org/10.1017/s1431927610057569

Quantitative Characterisation of Surface and Interface Chemistry with X-ray Photoelectron Spectroscopy (XPS)

Autor: Tim Nunney, RG White, O Mustonen

Publikováno v: Microscopy and Microanalysis. 15:176-177

Extended abstract of a paper presented at Microscopy and Microanalysis 2009 in Richmond, Virginia, USA, July 26 – July 30, 2009

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6d7a227a65983bf6d15ead3e30bb53a6
https://doi.org/10.1017/s1431927609096615

Pralidoxime mesylate absorption and heart rate response to atropine sulphate following intramuscular administration of solution mixtures

Autor: RG White, DC Parkes, P Holland

1. The oxime pralidoxime mesylate (P2S) and atropine sulphate, alone and mixed, have been administered intramuscularly to forty-four human subjects. Doses of 750 mg and 500 mg P2S and 2.0 mg atropine sulphate were used. 2. The presence of P2S had no

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8375c31651f5646e6b98eb4dbd742f27
https://europepmc.org/articles/PMC1402609/

Implications of subclinical tuberculosis for vaccine trial design and global effect.

Autor: Churchyard GJ; Aurum Institute NPC, Houghton, Parktown, South Africa; Department of Medicine, Vanderbilt University, Nashville, TN, USA; School of Public Health, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa. Electronic address: gchurchyard@auruminstitute.org., Houben RMGJ; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; TB Modelling Group, TB Centre, London School of Hygiene & Tropical Medicine, London, UK., Fielding K; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK., Fiore-Gartland AL; University of Washington, Seattle, WA, USA., Esmail H; MRC Clinical Trials Unit, University College London, London, UK; WHO Collaborating Centre for TB Research and Innovation, Institute for Global Health, University College London, London, UK., Grant AD; TB Centre, London School of Hygiene & Tropical Medicine, London, UK; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK; Africa Health Research Institute, KwaZulu-Natal, Durban, South Africa., Rangaka MX; MRC Clinical Trials Unit, University College London, London, UK; CIDRI-AFRICA, School of Public Health, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Behr M; McGill International TB Centre, McGill University, Montreal, QC, Canada., Garcia-Basteiro AL; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFECT), Barcelona, Spain., Wong EB; Africa Health Research Institute, KwaZulu-Natal, Durban, South Africa; Division of Infectious Diseases, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Hatherill M; South African Tuberculosis Vaccine Initiative, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Mave V; Byramjee-Jeejeebhoy Government Medical College, Johns Hopkins University Clinical Research Site, Pune, India., Dagnew AF; Gates Medical Research Institute, Cambridge, MA, USA., Schmidt AC; Gates Medical Research Institute, Cambridge, MA, USA., Hanekom WA; Division of Infection and Immunity, University College London, London, UK; Africa Health Research Institute, KwaZulu-Natal, Durban, South Africa., Cobelens F; Department of Global Health and Amsterdam Institute for Global Health and Development, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands., White RG; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; TB Modelling Group, TB Centre, London School of Hygiene & Tropical Medicine, London, UK.

Publikováno v: The Lancet. Microbe [Lancet Microbe] 2024 Oct; Vol. 5 (10), pp. 100895. Date of Electronic Publication: 2024 Jul 01.

Potential of Pan-Tuberculosis Treatment to Drive Emergence of Novel Resistance.

Autor: McQuaid CF, Ryckman TS, Menzies NA, White RG, Cohen T, Kendall EA

Publikováno v: Emerging infectious diseases [Emerg Infect Dis] 2024 Aug; Vol. 30 (8), pp. 1571-1579.